Jeffrey Rona

Chief Business and Financial Officer at Ovid Therapeutics

Jeffrey Rona is the Chief Business and Financial Officer Officer at Ovid. He is responsible for leading Ovid’s capital formation with investor groups and strategic corporate partnerships. Mr. Rona joined Ovid as consulting chief financial officer in 2019 to assist the company with strategic financings, including Ovid’s partnership with Angelini. He brings more than 25 years of experience to the role, both as a former investment banker and a strategic financial executive with expertise in financial operations, investor relations and raising capital for public and private companies. He previously held senior leadership positions for GlobeImmune, AlgoRx Pharmaceuticals and Antigenics, and later formed a successful life sciences financial advisory practice. Mr. Rona began his career at Coopers & Lybrand and UBS Investment Bank, and holds a B.S. in accounting from Case Western Reserve University.

Links

Timeline

  • Chief Business and Financial Officer

    October, 2020 - present

  • Chief Business Officer

    June, 2021

  • CFO

View in org chart